PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16849647-5	2006	Moreover, the BCR/ABL tyrosine kinase inhibitors imatinib (STI571) and nilotinib (AMN107) decreased histamine levels and HDC mRNA expression in BCR/ABL-transformed Ba/F3 cells, in the CML-derived basophil cell line KU812, and in primary CML cells.	Histamine	100-109	c-abl oncogene 1, non-receptor tyrosine kinase	Mus musculus	18-21	
24367707-6	2013	Notably, Abl kinase inhibition also impaired endothelial permeability in response to the inflammatory mediators thrombin and histamine.	Histamine	125-134	c-abl oncogene 1, non-receptor tyrosine kinase	Mus musculus	9-12	
29157947-10	2018	CONCLUSION: IL-4 amplifies IgE- and histamine-induced VE dysfunction, fluid extravasation, and the severity of anaphylaxis through a VE IL-4Ralpha/ABL1-dependent mechanism.	Histamine	36-45	c-abl oncogene 1, non-receptor tyrosine kinase	Mus musculus	147-151